A novel native derived coronary artery tissue-flap model

Tissue Engineering - Part C: Methods

Volumn 19, Issue 12, 2013, Pages 970-980

  Aubin, Hug ^a   Kranz, Alexander ^a   Hülsmann, Jörn ^a   Pinto, Antonio ^a   Barth, Mareike ^a   Fomin, Andrey ^a   Lichtenberg, Artur ^a   Akhyari, Payam ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; ENDOTHELIAL CELLS; HEART; PATENTS AND INVENTIONS; STEM CELLS; TISSUE ENGINEERING;

CORONARY ARTERIES; CURRENT LIMITATION; ENDOTHELIAL FUNCTION; EXTRACELLULAR MATRICES; PROTEIN DIFFUSIVITIES; STEM CELL DIFFERENTIATION; VASCULAR ARCHITECTURE; VASCULAR BIOLOGY;

TISSUE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL TYPE; COCULTURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY TISSUE FLAP; DRUG SCREENING; EXTRACELLULAR MATRIX; FEMALE; HEART MUSCLE CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; STEM CELL; TISSUE ENGINEERING; TISSUE FLAP; VASCULAR BIOLOGY; VASCULARIZATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CORONARY VESSELS; MODELS, CARDIOVASCULAR; MYOCARDIUM; RATS; RATS, WISTAR;

EID: 84888362247     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2012.0712     Document Type: Article

References (21)

1. WHO, World Heart Federation, World Stroke Organization. Global Atlas on cardiovascular disease prevention and control. WHO, Geneva, Switzerland, 2011.
2. Vunjak-Novakovic, G., Lui, K.O., Tandon, N., and Chien, K.R. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 13, 245, 2011.
3. Novosel, E.C., Kleinhans, C., and Kluger, P.J. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 63, 300, 2011.
4. Jain, R.K., Au, P., Tam, J., Duda, D.G., and Fukumura, D. Engineering vascularized tissue. Nat Biotechnol 23, 821, 2005.
5. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
6. Aird, W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100, 158, 2007.
7. Aird, W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100, 174, 2007.
8. Hsieh, P.C., Davis, M.E., Lisowski, L.K., and Lee, R.T. Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol 68, 51, 2006.
9. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., and Taylor, D.A. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
10. Akhyari, P., Aubin, H., Gwanmesia, P., Barth, M., Hoffmann, S., Huelsmann, J., et al. The quest for an optimized protocol for whole-heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng Part C Methods 17, 915, 2011.
11. Akhyari, P., Kamiya, H., Gwanmesia, P., Aubin, H., Tschierschke, R., Hoffmann, S., et al. In vivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position. Eur J Cardiothorac Surg 38, 539, 2010.
12. Akhyari, P., Fedak, P.W., Weisel, R.D., Lee, T.Y., Verma, S., Mickle, D.A., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106(12 Suppl1), I137, 2002.
13. Kannan, R.Y., Salacinski, H.J., Sales, K., Butler, P., and Seifalian, A.M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: A review. Biomaterials 26, 1857, 2005.
14. Mertsching, H., Walles, T., Hofmann, M., Schanz, J., and Knapp, W.H. Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomaterials 26, 6610, 2005.
15. Uygun, B.E., Soto-Gutierrez, A., Yagi, H., Izamis, M.L., Guzzardi, M.A., Shulman, C., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16, 814, 2010.
16. Petersen, T.H., Calle, E.A., Zhao, L., Lee, E.J., Gui, L., Raredon, M.B., et al. Tissue-engineered lungs for in vivo implantation. Science 329, 538, 2010.
17. Ba? r, A., Dorfman, S.E., Fischer, P., Hilfiker-Kleiner, D., Cebotari, S., Tudorache, I., et al. The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro. Cardiovasc Res 85, 806, 2010.
18. Mertsching, H., Schanz, J., Steger, V., Schandar, M., Schenk, M., Hansmann, J., et al. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation 88, 203, 2009.
19. Gantenbein-Ritter, B., Sprecher, C.M., Chan, S., Illien-Junger, S., and Grad, S. Confocal imaging protocols for live/dead staining in three-dimensional carriers. Methods Mol Biol 740, 127, 2011.
20. Grosberg, A., Alford, P.W., McCain, M.L., and Parker, K.K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip. Lab Chip 11, 4165, 2011.
21. Schussler, O., Chachques, J.C., Mesana, T.G., Suuronen, E.J., Lecarpentier, Y., and Ruel, M. 3-dimensional structures to enhance cell therapy and engineer contractile tissue. Asian Cardiovasc Thorac Ann 18, 188, 2010.